Finance
Markets

ABBV

stock NYSE
AbbVie Inc.
$214.50 +2.20 (+1.04%) At close

Key stats

The day open and close within the day's range
Low $209.50 High $215.64
Open
$210.95
-0.64%
Close
$214.50
+1.04%
52-week range where the price sits across its year
52w low $180.25 52w high $244.81
Current
$214.50
Prev close
$212.30
Volume 0.57× the 3-month average
0 avg 2× avg
Today
3.81M
3-mo avg
6.69M

Fundamentals

Each ratio reads FY2025 figures against the latest price, graded so the quality shows at a glance.

P/E ratio Weak
90.9x

At 91x, the price is steep relative to profit; the stock leans heavily on growth that has yet to arrive.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Strong
3.10%

A 3.1% yield is a healthy, generally sustainable level of cash income.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
6.9%

A 6.9% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity No data
·

Shareholder equity is negative, so return on equity is not meaningful.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
3.2%

A 3.2% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data
·

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Weak
0.67

At 0.67, short-term assets fall short of short-term bills; liquidity is tight.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+8.6%

Revenue grew 8.6% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-1.2%

Net income fell 1.2% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financials

FY2021FY2022FY2023FY2024FY2025
Revenue $56.2B$58.1B$54.3B$56.3B$61.2B
Net income $11.5B$11.8B$4.9B$4.3B$4.2B
Diluted EPS $6.45$6.63$2.72$2.39$2.36
Dividend / share $1.30$5.71$5.99$6.29$6.65
Total assets $146.5B$138.8B$134.7B$135.2B$134.0B
Total liabilities ·····
Shareholder equity $15.4B$17.3B$10.4B$3.3B-$3.3B

Recent SEC filings